Details for New Drug Application (NDA): 091671
✉ Email this page to a colleague
NDA 091671 describes HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX, which is a drug marketed by Neos Theraps Inc and is included in one NDA. Additional details are available on the HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX profile page.
The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
Summary for 091671
| Tradename: | HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX |
| Applicant: | Neos Theraps Inc |
| Ingredient: | chlorpheniramine polistirex; hydrocodone polistirex |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION, EXTENDED RELEASE;ORAL | Strength | EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML | ||||
| Approval Date: | Jun 29, 2012 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
